Yisha Ng - Search Results

Year	Number of Results
2005	2
2006	1
2007	1
2008	1
2009	2
2010	3
2011	1
2012	1
2013	3
2014	5
2015	9
2016	7
2017	11
2018	20
2019	29
2020	30
2021	27
2022	18

1

COVID-19: immunopathogenesis and Immunotherapeutics.

Yang L, Liu S, Liu J, Zhang Z, Wan X, Huang B, Chen Y, Zhang Y. Yang L, et al. Signal Transduct Target Ther. 2020 Jul 25;5(1):128. doi: 10.1038/s41392-020-00243-2. Signal Transduct Target Ther. 2020. PMID: 32712629 Free PMC article. Review.

2

HMGB1 in inflammation and cancer.

Wang S, Zhang Y. Wang S, et al. J Hematol Oncol. 2020 Aug 24;13(1):116. doi: 10.1186/s13045-020-00950-x. J Hematol Oncol. 2020. PMID: 32831115 Free PMC article.

3

Immunosenescence: a key player in cancer development.

Lian J, Yue Y, Yu W, Zhang Y. Lian J, et al. J Hematol Oncol. 2020 Nov 10;13(1):151. doi: 10.1186/s13045-020-00986-z. J Hematol Oncol. 2020. PMID: 33168037 Free PMC article. Review.

4

SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19.

Zhang S, Liu Y, Wang X, Yang L, Li H, Wang Y, Liu M, Zhao X, Xie Y, Yang Y, Zhang S, Fan Z, Dong J, Yuan Z, Ding Z, Zhang Y, Hu L. Zhang S, et al. J Hematol Oncol. 2020 Sep 4;13(1):120. doi: 10.1186/s13045-020-00954-7. J Hematol Oncol. 2020. PMID: 32887634 Free PMC article.

5

T-cell receptor-engineered T cells for cancer treatment: current status and future directions.

Ping Y, Liu C, Zhang Y. Ping Y, et al. Protein Cell. 2018 Mar;9(3):254-266. doi: 10.1007/s13238-016-0367-1. Epub 2017 Jan 20. Protein Cell. 2018. PMID: 28108950 Free PMC article. Review.

6

Lung adenocarcinoma-intrinsic GBE1 signaling inhibits anti-tumor immunity.

Li L, Yang L, Cheng S, Fan Z, Shen Z, Xue W, Zheng Y, Li F, Wang D, Zhang K, Lian J, Wang D, Zhu Z, Zhao J, Zhang Y. Li L, et al. Mol Cancer. 2019 Jun 20;18(1):108. doi: 10.1186/s12943-019-1027-x. Mol Cancer. 2019. PMID: 31221150 Free PMC article.

7

Gene modification strategies for next-generation CAR T cells against solid cancers.

Tian Y, Li Y, Shao Y, Zhang Y. Tian Y, et al. J Hematol Oncol. 2020 May 18;13(1):54. doi: 10.1186/s13045-020-00890-6. J Hematol Oncol. 2020. PMID: 32423475 Free PMC article. Review.

8

Hypoxia-induced GBE1 expression promotes tumor progression through metabolic reprogramming in lung adenocarcinoma.

Li L, Yang L, Fan Z, Xue W, Shen Z, Yuan Y, Sun X, Wang D, Lian J, Wang L, Zhao J, Zhang Y. Li L, et al. Signal Transduct Target Ther. 2020 May 22;5(1):54. doi: 10.1038/s41392-020-0152-8. Signal Transduct Target Ther. 2020. PMID: 32439898 Free PMC article.

9

Colorectal cancer cell-derived CCL20 recruits regulatory T cells to promote chemoresistance via FOXO1/CEBPB/NF-κB signaling.

Wang D, Yang L, Yu W, Wu Q, Lian J, Li F, Liu S, Li A, He Z, Liu J, Sun Z, Yuan W, Zhang Y. Wang D, et al. J Immunother Cancer. 2019 Aug 8;7(1):215. doi: 10.1186/s40425-019-0701-2. J Immunother Cancer. 2019. PMID: 31395078 Free PMC article.

10

Cancer-cell-secreted CXCL11 promoted CD8⁺ T cells infiltration through docetaxel-induced-release of HMGB1 in NSCLC.

Gao Q, Wang S, Chen X, Cheng S, Zhang Z, Li F, Huang L, Yang Y, Zhou B, Yue D, Wang D, Cao L, Maimela NR, Zhang B, Yu J, Wang L, Zhang Y. Gao Q, et al. J Immunother Cancer. 2019 Feb 11;7(1):42. doi: 10.1186/s40425-019-0511-6. J Immunother Cancer. 2019. PMID: 30744691 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results